Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06050915 · ClinicalTrials.gov registry record · Phase 1
A Study of DISC-3405 in Healthy Volunteers
A Phase 1 study, sponsored by Disc Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
NCT06050915 is a Phase 1 study that has completed, run by Disc Medicine. The registered enrollment target is 64 participants.
The verdict
NCT06050915, a Phase 1 study, has completed, sponsored by Disc Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
This phase 1 study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of DISC-3405 in adult male and female healthy volunteers.
Interventions
- DRUG Placebo
- DRUG DISC-3405
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-10-03 |
| Est. Completion | 2024-07-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06050915
The ClinicalTrials.gov registry entry for NCT06050915 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Disc Medicine, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06050915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06050915 about?
NCT06050915 is a clinical study titled "A Study of DISC-3405 in Healthy Volunteers". This phase 1 study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of DISC-3405 in adult male and female healthy volunteers.
What is the current status of trial NCT06050915?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2023-10-03. Estimated completion is 2024-07-09.
What interventions are being tested in trial NCT06050915?
The interventions under investigation include: Placebo (DRUG), DISC-3405 (DRUG).
Who is sponsoring clinical trial NCT06050915?
This trial is sponsored by Disc Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.